Citadel Advisors
LABX

Citadel Advisors’s Tradr 2X Long ALAB Daily ETF LABX Stock Holding History

Citadel Advisors’s Portfolio LABX Stock Details LABX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,956
Closed -$152K – 14675
2025
Q3 		$234K Buy
+16,956
New +$263K ﹤0.01% 10897

Other funds holding LABX

Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors's LABX Position: Q4 2025 in Review

Citadel Advisors sold out of Tradr 2X Long ALAB Daily ETF (LABX) in Q4 2025, closing a stake of 16,956 shares — an estimated $152K sold.

Citadel Advisors first reported a position in LABX in Q3 2025 and held it in 1 quarter. The position peaked at $234K in Q3 2025. 7 funds tracked by Wall St. Rank hold LABX as of Q4 2025.

  • Citadel Advisors reported no remaining Tradr 2X Long ALAB Daily ETF position as of Q4 2025 after selling out during the quarter.
  • Citadel Advisors sold 16,956 Tradr 2X Long ALAB Daily ETF shares in Q4 2025, an estimated $152K.
  • Citadel Advisors first reported a position in Tradr 2X Long ALAB Daily ETF in Q3 2025 and held it in 1 quarter.
  • Citadel Advisors's Tradr 2X Long ALAB Daily ETF position peaked at $234K in Q3 2025.
  • 7 funds tracked by Wall St. Rank held Tradr 2X Long ALAB Daily ETF as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.